Fundamental Analysis of OCUGEN INC(NASDAQ:OCGN) stock

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to OCGN. OCGN was compared to 588 industry peers in the Biotechnology industry. Both the profitability and financial health of OCGN have multiple concerns. While showing a medium growth rate, OCGN is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

OCGN had negative earnings in the past year.

OCGN had a negative operating cash flow in the past year.

OCGN had negative earnings in each of the past 5 years.

OCGN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -97.73%, OCGN is doing worse than 76.88% of the companies in the same industry.

The Return On Equity of OCGN (-155.51%) is worse than 66.78% of its industry peers.

		Industry Rank	Sector Rank
ROA	-97.73%
ROE	-155.51%
ROIC	N/A

ROA(3y)-75.93%

ROA(5y)-94.74%

ROE(3y)-104.39%

ROE(5y)-131.26%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

OCGN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OCGN does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for OCGN has been increased compared to 1 year ago.

The number of shares outstanding for OCGN has been increased compared to 5 years ago.

The debt/assets ratio for OCGN is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -1.41, we must say that OCGN is in the distress zone and has some risk of bankruptcy.

OCGN has a Altman-Z score (-1.41) which is comparable to the rest of the industry.

A Debt/Equity ratio of 0.07 indicates that OCGN is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.07, OCGN is doing worse than 62.84% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	N/A
Altman-Z	-1.41

ROIC/WACCN/A

WACC9.25%

2.3 Liquidity

A Current Ratio of 2.51 indicates that OCGN has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 2.51, OCGN is doing worse than 72.95% of the companies in the same industry.

A Quick Ratio of 2.51 indicates that OCGN has no problem at all paying its short term obligations.

OCGN has a worse Quick ratio (2.51) than 70.89% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.51
Quick Ratio	2.51

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.84% over the past year.

Measured over the past years, OCGN shows a very strong growth in Revenue. The Revenue has been growing by 432.39% on average per year.

EPS 1Y (TTM)36.84%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q70%

Revenue 1Y (TTM)N/A

Revenue growth 3Y432.39%

Revenue growth 5YN/A

Revenue growth Q2QN/A

3.2 Future

Based on estimates for the next years, OCGN will show a very strong growth in Earnings Per Share. The EPS will grow by 27.43% on average per year.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-19%

EPS Next 2Y-5.12%

EPS Next 3Y27.32%

EPS Next 5Y27.43%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

OCGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year OCGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

OCGN's earnings are expected to grow with 27.32% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-5.12%

EPS Next 3Y27.32%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for OCGN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

OCUGEN INC

NASDAQ:OCGN (4/25/2024, 3:56:21 PM)

After market: 1.2 +0.02 (+1.69%)

1.18

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap302.79M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-97.73%
ROE	-155.51%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.09

Health

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	2.51
Quick Ratio	2.51
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)36.84%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-19%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)N/A

Revenue growth 3Y432.39%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

OCUGEN INC (OCGN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens